Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease
Cardiovascular Research · 22.05.2023 · 119 (5) · 1279-1294
DOI: 10.1093/cvr/cvac138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 22.08.2022. Verfasst von Matt D Worssam und 14 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis, Spinocerebellar Ataxias. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Council, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Aims
Quiescent, differentiated adult vascular smooth muscle cells (VSMCs) can be induced to proliferate and switch phenotype. Such plasticity underlies blood vessel homeostasis and contributes to vascular disease development. Oligoclonal VSMC contribution is a hallmark of end-stage vascular disease. Here, we aim to understand cellular mechanisms underpinning generation of this VSMC oligoclonality. Methods and results We investigate the dynamics of VSMC clone formation using confocal microscopy and single-cell transcriptomics in VSMC-lineage-traced animal models. We find that activation of medial VSMC proliferation occurs at low frequency after vascular injury and that only a subset of expanding clones migrate, which together drives formation of oligoclonal neointimal lesions. VSMC contribution in small atherosclerotic lesions is typically from one or two clones, similar to observations in mature lesions. Low frequency (<0.1%) of clonal VSMC proliferation is also observed in vitro. Single-cell RNA-sequencing revealed progressive cell state changes across a contiguous VSMC population at onset of injury-induced proliferation. Proliferating VSMCs mapped selectively to one of two distinct trajectories and were associated with cells showing extensive phenotypic switching. A proliferation-associated transitory state shared pronounced similarities with atypical SCA1+ VSMCs from uninjured mouse arteries and VSMCs in healthy human aorta. We show functionally that clonal expansion of SCA1+ VSMCs from healthy arteries occurs at higher rate and frequency compared with SCA1− cells.
Conclusion
Our data suggest that activation of proliferation at low frequency is a general, cell-intrinsic feature of VSMCs. We show that rare VSMCs in healthy arteries display VSMC phenotypic switching akin to that observed in pathological vessel remodelling and that this is a conserved feature of mouse and human healthy arteries. The increased proliferation of modulated VSMCs from healthy arteries suggests that these cells respond more readily to disease-inducing cues and could drive oligoclonal VSMC expansion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB, UK.
- Babraham Institute, Cambridge, UK.
- Functional Gene Control Group, MRC London Institute of Medical Sciences, London, UK.
- Institute of Clinical Sciences, Imperial College London, London, UK.
ORCID-Profile: Matt D Worssam, Jordi Lambert, Sebnem Oc, Joel Chappell, Jennifer L Harman, Alison Finigan, Martin R Bennett, Mikhail Spivakov, Helle F Jørgensen
Förderung
- British Heart Foundation
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- BHF Cambridge Centre of Research Excellence
- BHF Chair awards
- Cambridge NIHR Biomedical Research Centre
Zitieren
APA
Worssam, M. D., Lambert, J., Oc, S., Taylor, J. C. K., Taylor, A. L., Dobnikar, L., Chappell, J., Harman, J. L., Figg, N. L., Finigan, A., Foote, K., Uryga, A. K., Bennett, M. R., Spivakov, M., & Jørgensen, H. F. (2023). Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease. Cardiovascular Research, 119(5), 1279-1294. https://doi.org/10.1093/cvr/cvac138
Vancouver
Worssam MD, Lambert J, Oc S, Taylor JCK, Taylor AL, Dobnikar L, et al. Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease. Cardiovascular Research. 2023;119(5):1279-1294. doi:10.1093/cvr/cvac138
BibTeX
@article{Worssam2023,
author = {Worssam, Matt D and Lambert, Jordi and Oc, Sebnem and Taylor, James C K and Taylor, Annabel L and Dobnikar, Lina and Chappell, Joel and Harman, Jennifer L and Figg, Nichola L and Finigan, Alison and Foote, Kirsty and Uryga, Anna K and Bennett, Martin R and Spivakov, Mikhail and Jørgensen, Helle F},
title = {Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {5},
pages = {1279--1294},
doi = {10.1093/cvr/cvac138}
}
EUVIMED